| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.905 | 45.699 | 50.269 | 57.173 | 53.896 | 45.524 | 56.403 | 72.565 | 64.788 | 67.322 |
| Total Income - EUR | 9.905 | 45.699 | 50.269 | 57.173 | 53.896 | 45.524 | 56.682 | 72.565 | 64.808 | 67.650 |
| Total Expenses - EUR | 15.605 | 32.626 | 29.898 | 31.487 | 31.562 | 24.178 | 33.122 | 43.991 | 41.307 | 42.988 |
| Gross Profit/Loss - EUR | -5.701 | 13.074 | 20.371 | 25.685 | 22.334 | 21.345 | 23.560 | 28.574 | 23.501 | 24.663 |
| Net Profit/Loss - EUR | -5.991 | 11.927 | 19.868 | 25.114 | 21.795 | 21.029 | 23.163 | 27.863 | 22.950 | 22.674 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Genetrixmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.326 | 17.822 | 13.608 | 9.518 | 6.332 | 4.765 | 29.263 | 22.885 | 13.466 | 6.418 |
| Current Assets | 5.082 | 11.487 | 17.149 | 16.947 | 16.921 | 37.321 | 23.795 | 7.912 | 36.795 | 18.397 |
| Inventories | 1.402 | 1.454 | 1.433 | 1.475 | 1.732 | 1.263 | 1.908 | 1.942 | 2.584 | 2.122 |
| Receivables | 1.113 | 746 | 858 | 1.192 | 816 | 971 | 1.601 | 1.084 | 1.064 | 1.094 |
| Cash | 2.567 | 9.287 | 14.858 | 14.280 | 14.373 | 35.087 | 20.286 | 4.886 | 33.146 | 15.181 |
| Shareholders Funds | -5.946 | 6.041 | 25.808 | 25.165 | 21.846 | 41.373 | 50.851 | 27.911 | 49.368 | 22.722 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.355 | 23.267 | 4.950 | 1.300 | 1.407 | 714 | 2.207 | 2.886 | 892 | 2.092 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Genetrixmed Srl